Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Pernix Therapeutics to Report Second Quarter 2018 Financial Results on Thursday, August 9

Posted on: 31 Jul 18

MORRISTOWN, N.J., July 31, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that the Company will report financial results for the second quarter and six months ended June 30, 2018, after the market close on Thursday, August 9, 2018.  Pernix management will also host a conference call at 4:30 pm Eastern Time to discuss the results.

Date: Thursday, August 9
Time:  4:30 PM ET 
Toll free (U.S.):    866-548-4713
International:  323-794-2093
Conference ID:    9816665 

About Pernix Therapeutics
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market.  The Company is currently focused on the therapeutic areas of Pain and Neurology, and has an interest in expanding into additional specialty segments.  The Company promotes its branded products to physicians through its internal sales force and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.

To learn more about Pernix Therapeutics, visit

Investor Relations
Bob Yedid
LifeSci Advisors, LLC


Last updated on: 01/08/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.